Evidence map›Paper›PMID 28750062›Full record

ArticlePloS one2017

The effect of mangiferin on skin: Penetration, permeation and inhibition of ECM enzymes.

Renata Ochocka, Anna Hering, Justyna Stefanowicz-Hajduk, Krzysztof Cal, Helena Barańska

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. The Potential ofAntioxidants (Basel, Switzerland) · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Utilisation ofFuture journal of pharmaceutical sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Renata OchockaDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.ORCID http://orcid.org/0000-0002-4424-3667
Anna HeringDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Justyna Stefanowicz-HajdukDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Krzysztof CalDepartment of Pharmaceutical Technology, Medical University of Gdansk, Gdansk, Poland.
Helena BarańskaDepartment of Pharmaceutical Technology, Medical University of Gdansk, Gdansk, Poland.
Gdańsk Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mangiferin (2-C-β-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone) is a polyphenol with strong antioxidant properties. Mangiferin is obtained from the mango tree (Mangifera indica L., Anacardiaceae). It has been proven that mangiferin exhibits many pharmacological activities. The aim of this study was to analyze the penetration of mangiferin into the human skin and through the skin. According to our knowledge, skin penetration and permeation studies of mangiferin have not been analyzed so far. Additionally, the influence of mangiferin on two Extracellular Matrix Enzymes (ECM): collagenase and elastase, was evaluated for the first time. It has been indicated that mangiferin is able to permeate the stratum corneum and penetrate into the epidermis and dermis in comparable amounts. For confirmation of the obtained results, fluorescence microscopy was successfully utilized. The analysis revealed the capability of mangiferin to reversibly inhibit elastase and collagenase activity. The mechanism of mangiferin interaction with both enzymes was estimated as a noncompetitive inhibition.

Indexed as

AdultCollagenasesEnzyme InhibitorsExtracellular MatrixHumansKineticsMiddle AgedPancreatic ElastaseSkinSkin AbsorptionSolutionsXanthonesCollagenasesEnzyme InhibitorsmangiferinPancreatic ElastaseSolutionsXanthones

Identifiers

PMID28750062
PMCPMC5531637
OpenAlexW2741078826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.